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Abstract
Background: Violence during pregnancy is a global problem, associated with serious health risks for both the
mother and baby. Evaluation of interventions targeted for reducing or controlling domestic violence (DV) is still in
its infancy, and the majority of findings are primarily from high-income countries (HICs). Therefore, there is an
urgent need for generating evidence of DV interventions among pregnant women in low- and middle-income
countries (LMICs).
Methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines will be employed
to structure the review. A comprehensive search will be carried out via electronic databases including MEDLINE,
CINAHL, Scopus, Embase, Web of Science, PsycINFO, and The Cochrane library. Gray literature will also be scrutinized
for potential articles. An optimal search strategy has been developed following consultations with subject-matter
experts and librarians. This search strategy will be adapted to the different databases. Experimental studies evaluating
DV interventions among pregnant women from LMICs will be included in the review. The review will only include
literature written in English. Two reviewers will independently screen and assess studies for inclusion in the review. A
third author will resolve any discrepancies between the reviewers. Risk of bias will be assessed based on the Cochrane
risk of bias assessment tool, and overall quality of the evidence will be judged using Grading of Recommendations,
Assessment, Development, and Evaluation (GRADE) criteria. Findings will be presented with the narrative synthesis, and
if applicable, they will be further quantified using random-effects meta-analysis. Effect size, risk ratio for dichotomous
variables, and standardized mean differences for continuous variables will be calculated for each outcome using
Review Manager 5.3.
Discussion: Systematic reviews to evaluate the efficacy of interventions to address DV within the perinatal context have
been limited. Hence, no one intervention has emerged as substantially effective towards addressing perinatal DV and
associated health consequences. The evidence generated from this systematic review will inform researchers and
policy makers about the effectiveness of existing DV interventions among pregnant women in LMICs and provide
recommendations for future research in this area. This in turn will contribute towards violence prevention in LMICs.
Systematic review registration: PROSPERO CRD42017073938
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Background
Statement of the problem
Violence against women (VAW) is a leading preventable
contributor to death and disability and a significant eco-
nomic burden [1]. Intimate partner violence (IPV) is the
most common form of VAW and includes physical, sexual,
and emotional abuse and controlling behaviors by an in-
timate partner [1, 2]. Globally, one in three women expe-
riences violence from an intimate partner and one of the
regions witnessing its highest prevalence is the South East
Asian region (37.7%) [1]. Domestic violence (DV) is a term
used in many countries, including low-and middle-income
countries (LMICs), to refer to partner violence, but the
term can also encompass child or elder abuse, or any other
forms of abuse by any member of a household [2, 3]. In
this review, domestic violence (DV) will be used to refer to
any violence perpetrated against women by an intimate
partner or by someone in her family relationship [2, 4].
Many women experience violence and abuse around the
time of pregnancy [4, 5]. DV during pregnancy is more
common than pre-eclampsia and placenta previa; notwith-
standing this, it receives much less attention in perinatal
care settings [5]. The WHO multi-country population
survey, conducted in ten countries, identified the preva-
lence rate of DV during pregnancy ranging from 1% in
urban Japan to 28% in provincial Peru [4]. A recent meta-
analysis further supports its omnipresence reporting a
higher proportion of victims from developing countries
than developed countries (27.7 vs 13.3%) [6]. However,
these prevalence rates are likely to be underestimated as
they are based on self-reporting; with many women pre-
ferring to keep their history of violence in silence because
of stigma, shame, and fear of retaliation [7].
DV during pregnancy is particularly alarming in light
of its severe negative effects on the physical and mental
health and well-being of both mother and child, and its
overall effect on family functioning [8–10]. Evidence
suggests DV during pregnancy is one of the strongest
predictors for a wide array of mental health problems,
such as anxiety, depression, post-traumatic stress dis-
order (PTSD) [11, 12], and persistent episodes of DV ex-
erts soaring negative effects on mental health [13].
Similarly, almost one in every two women with mental
illness is at risk of becoming a victim of DV [14, 15].
These figures support the reciprocal or cyclical relation-
ship between violence and mental illness during preg-
nancy, both of which remain the major source of
maternal morbidities [14]. It is unclear whether violence
leads to mental illness or mental illness leads to violence
or both morbidities coexist [3, 14, 16].
Description of available interventions
Globally, various interventions have been developed for
reducing DV and improving health outcomes. DV
screening accompanied by comprehensive therapeutic
intervention, such as counseling, psychotherapy, and home
visiting, has shown some encouraging results [17–19]. Ar-
royo et al. concluded that the use of brief psychological
treatments, such as cognitive behavioral therapy and psy-
choeducation, were found to increase the self-esteem and
decrease the symptoms of depression and general distress
among abused women [19]. The Cochrane review in
2015 assessed the effects of advocacy interventions,
which included counseling, empathetic listening, and
addressing the provision of social support, among
women who have experienced abuse. The review con-
cluded that though advocacy appeared to reduce vio-
lence and improve health outcomes, the magnitude and
consistency of these benefits were uncertain [20]. An-
other systematic review conducted in 2015 reviewed 19
randomized controlled trials (RCTs) evaluating the ef-
fectiveness of home-visiting interventions in reducing
partner violence. A home-visiting intervention, which
included support services to women, was found effect-
ive in reducing DV in short term; however, there was
no evidence that this change was sustained in the long
term [21]. Nevertheless, regardless of the evidence base
for interventions related to violence in the last decade,
minimum research has stemmed from developing
countries. Indeed, a disproportionately high number of
the studies are based in high-income countries (HICs),
and most of them do not consider DV in the context of
pregnancy [17–21].
Pregnancy can be a critical turning point in a woman’s
life [22]; some women may find it exceptionally stressful
because of the physical, emotional, social, and economic
changes in roles and needs that they may experience [23].
This may impede women’s coping skills, leading to an in-
creased risk or escalation of domestic violence [22, 23].
Yet, at the same time, pregnancy presents a unique oppor-
tunity to identify victims and offer support to them be-
cause of repeated interactions with health care providers
(HCPs) from early pregnancy to postpartum [5, 24]. The
risk of abuse and the ability to access support services [3,
5] are entirely different for pregnant women; therefore, it
is important to identify a tailored DV intervention which
has the potential to meet the needs and expectations of
pregnant women.
Jahanfar et al. [25] and Van Parys et al. [26] evaluated
DV interventions around the time of pregnancy. Both re-
views identified a number of DV interventions, including
a single, brief, and individualized consultation to multiple
therapy sessions both during pregnancy and after birth
[25, 26]. Advocacy interventions consisting of supportive
counseling, empathetic listening, and provision of social
support were effective in reducing DV, depression, and
other postpartum affective disorders [27, 28]. Home-
visiting interventions aimed at enhancing maternal and
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child health and promoting healthy relationships were
also found to reduce DV victimization in three studies
[29–31]. Even so, due to a limited number of studies
and lack of consistency in the outcomes, a meta-analysis
could not be performed in either review [25, 26]. Conse-
quently, both reviews were unable to provide a strong evi-
dence base which would support the adoption of any
intervention in the perinatal care context.
Rationale for the current review
Even though RCTs are considered to be the gold stand-
ard for effectiveness studies [32], the ability to conduct
such trials in LMICs are severely hampered by several
logistical challenges [32, 33]. For example, in resource-
constrained settings, there is a paucity of facilities,
trained human resources, and expertise. Thus, the exe-
cution of randomized trials is hindered and limited by
both high costs and time requirements [32, 33]. Further-
more, employing RCTs in complex public health interven-
tions may be inappropriate, misleading, or unnecessarily
expensive [33]. This may then partially explain why there
are a minimal number of RCTs evaluating DV interven-
tions in LMICs [25, 26]. However, having a small number
of RCTs does not necessarily imply that prevention pro-
grams are not occurring in developing countries [8, 34],
but to date, many of them may not have been employing a
rigorous methodology [34]. A number of government and
civil society organizations are now striving to develop in-
terventions and resources to address DV in LMICs [34].
Indeed, a number of new interventions have been devel-
oped in recent years, but they have not been systematically
assessed for comparative efficacy. Hence, this review will
include a broader range of studies (both randomized con-
trolled trials and non-randomized studies) to understand
and incorporate a wider body of DV interventions that
have been implemented and evaluated for pregnant
women in LMICs.
The application of theory is advocated as an integral
step in intervention design and evaluation and in evi-
dence synthesis [35]. Theory-based behavior change in-
terventions were found effective in various health
promotion and disease prevention domains, such as IPV
[31], HIV [36], and menopausal symptoms [37]. These
interventions took into account the capacity and motiv-
ation of an individual to initiate and adhere to the
change. Previous reviews have assessed the impact of
DV interventions on several behavioral outcomes, such
as safety planning, use of community resources, help-
seeking behaviors, and self-efficacy, but, overall, they have
not considered the theoretical underpinnings of the inter-
ventions [20, 25, 26]. The most important distinction of
the current review will be the mapping of the multiple
theoretical pathways to tackle DV among pregnant
women. The review intends to provide a comprehensive
description and illustration of how and why a desired
change can be expected to occur in a particular context
because of intervention.
WHO review asserts that the generalizability of results
from HICs to LMICs cannot be assumed [8]. For ex-
ample, a number of studies from HICs are currently
using web-based interventions for behavioral changes in
sensitive or stigmatized issues such as mental health and
DV [38, 39]. Despite the effectiveness of such interven-
tions, it is not possible to generalize such findings to all
settings; this is particularly relevant to countries with
limited resources and limited access to technology and
the internet. For example, over 90% people from low-
income countries (LICs) have no access to the internet
[40] and computer literacy is generally low as well in
these countries [41]. Hence, it must be recognized that
an intervention that is successful in one context may not
be applicable or exerts similar effects in another context
[42, 43]. Several structural factors such as financial limi-
tations, inadequate human resources, cultural barriers,
social norms, and government policy may hinder the
ability of low- and middle-income settings to deliver the
interventions that have been successfully tested in HICs
[44]. Therefore, there is a need to generate an evidence
base from studies that can truly reflect the context of
LMICs. Consequently, the main aim of this systematic
review is to obtain a complete representation of inter-
vention programs and their effectiveness in addressing
DV and associated health consequences among pregnant
women in resource-constrained settings.
Review questions
 What are the effects of DV intervention on
reducing the frequency and/or severity of DV
among pregnant women in LMICs?
 What are the effects of DV interventions on
secondary outcomes such as mental health,
help-seeking behaviors, and use of community
resources among the pregnant women in LMICs?
 What common theories have guided the design
and/or implementation of DV interventions?
Methods
The Preferred Reporting Items for Systematic Reviews and
Meta-Analysis Protocols (PRISMA-P) recommendations
[45] have been used for preparing and reporting this sys-
tematic review protocol (see Additional file 1). This sys-
tematic review protocol has been registered in the
International Prospective Register of Systematic Reviews
(PROSPERO) with registration number CRD42017073938.
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Search strategy
Medical Subject Headings (MeSH), controlled vocabulary,
and key words have been used to identify articles. A com-
bination of four key concepts is used “Domestic Violence,”
“pregnant,” “LMICs,” and “intervention.” Boolean opera-
tors (“AND,” “OR,” and “NOT”) and proximity operators
(“NEAR,” “NEXT,” and “ADJ”) have been used to combine
search terms, and these operators will be adapted to
the syntax of different databases. The Cochrane Hand-
book has been referred to identify the search terms for
randomized and non-randomized study [46]. A com-
prehensive MEDLINE (Ovid) search strategy has been
developed through an iterative approach in consult-
ation with the health librarian and the review team
[Additional file 2]. Other databases such as CINAHL,
Web of Science, Scopus, Embase, The Cochrane Library
(Cochrane Database of Systematic Reviews, Cochrane
Central Register of Controlled Trials (CENTRAL)), and
psycINFO will be searched with appropriate modifica-
tion of MEDLINE strategy.
Several attempts will be made to search gray litera-
tures in a systematic and transparent way. Google
scholar, Cochrane Methodology Register, and WHO
International Clinical trials registry will be searched for
gray literatures presented as dissertations, abstracts, un-
published reports, and ongoing trials. Journals, such as
Journal of Interpersonal Violence, BMJ Injury Prevention,
British Journal of Obstetrics and Gynecology, BMC Preg-
nancy and Childbirth, Journal of Family Violence, Vio-
lence against Women, and Journal of Women’s Health
will be systematically scrutinized for relevant literature.
Reference lists and bibliography of the articles identified
from the database searches will be cross-checked to en-
sure literature saturation.
Inclusion criteria
Studies will be selected according to the PICOSS (partic-
ipants/population, intervention, comparisons, outcomes,
study designs, and settings) criteria outlined below:
 Participants: pregnant women of any age and/or
women who have given birth in the past 12 months.
 Interventions: the study must have evaluated an
intervention related to either DV or improving
relationship or gender related issues. Intervention
types may include, but not limited to, educational
programs, group training, advocacy, empowerment,
supportive counseling, referrals, home visitation,
couple counseling, and other forms of DV-related
intervention.
 Comparisons: either no intervention or usual care or
standard care will be eligible.
 Outcomes: the primary outcome of this review will
be self-reported measures of frequency and/or
severity of DV (either physical, sexual, or emotional).
Secondary outcomes will include the following:
– Changes in psychological or mental health
outcomes such as measures of quality of life,
depression, anxiety, stress, self-efficacy, and self-
esteem.
– Use of safety behaviors, access to community
resources, social support, and use of referral
services.
 Studies: randomized controlled trials (RCTs)
and non-randomized trials will be included.
Non-randomized studies (NRS) will include
non-randomized controlled trials (nRCT),
controlled before and after (CBA) studies, and
interrupted time series (ITS) studies.
 Settings: studies conducted in LMICs as listed by
World Bank 2017 [47] will be included.
Additional inclusion criteria
 Published and unpublished articles written in
English will be included. Reviewing published
articles only may be subjected to publication bias,
wherein positive results are over-emphasized due
to the tendency for null or negative results not to
get published [46]. Study protocols and conference
abstracts will only be included if they contain pilot
or preliminary results from the study whose data
are otherwise unavailable.
 Multiple papers from a single study will be
considered together and counted as one study.
The paper containing the most comprehensive
information will be included in data synthesis.
However, if other papers report on any additional
data or used different analytical methods across
different papers, then, additional data will also be
included.
Exclusion criteria
 Any qualitative investigations, book chapters, case
reports, letters, opinions, and editorials, will be
excluded.
 Cohort studies, case–control studies, cross-sectional
studies, will not be included.
 Studies conducted in HICs including women from
LMICs will be excluded.
Study selection
The bibliographic software program Endnote (V.X8) will
be used to manage and store relevant studies. Duplicate
references will be removed via this software. Electronic
searches will be scrutinized by two independent re-
viewers for eligibility and inclusion of studies into the
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review based on their title and abstract. This selection
process will be piloted using 10% of papers and agree-
ment between reviewers (DS and AS) will be assessed.
When a difference of opinion occurs, the issue will be
resolved with consensus involving a third reviewer (KB).
Full text of potentially relevant articles will be retrieved
and reviewed independently by two reviewers. A final in-
clusion or exclusion decision will be made on examin-
ation of full article, and reasons for exclusion will be
documented for each excluded study. Figure 1 presents
the flow diagram to be adopted in the systematic review
for selecting the studies [48].
Methodological appraisal of study
Classification of risk of bias as recommended by the
Cochrane handbook will be used to assess the quality of
selected RCTs. Main domains of bias assessment are se-
quence generation, allocation concealment, blinding (re-
search personnel, participants, and outcome assessment),
incomplete outcome data, selective reporting, and other
potential sources of bias. Each domain will be categorized
as low risk, high risk, and “unclear” if there will be an
unclear or unknown risk due to insufficient information
or lack of relevance [46]. For the non-randomized studies,
Risk of Bias in Non-randomized Studies − of Interventions
(ROBINS-I) assessment tool will be used [46].
Data extraction
Study findings will be extracted on a structured data-
base, developed in consultation with the research team.
It includes pertinent information such as study setting,
study population, sample size, study population’s demo-
graphics, baseline measurements, details related to inter-
vention and control conditions, theories used, study
methodology, response rates, follow-up, outcomes, times
of measurement, and assessment of risk of bias (see
Additional file 3). Data from individual studies will be
extracted by DS using a piloted extraction form and then
independently checked by AS. Discrepancies will be re-
solved by discussion and, where necessary, KB will make
the final judgment. New categories will be added and ex-
traction database will be modified as needed. Authors
will be contacted to supply missing data or other rele-
vant information if needed.
Fig. 1 PRISMA flow diagram
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Timing of outcome assessment
As there is no optimal time for follow-up, the duration
of follow-up in all studies will be documented. For the
purpose of this review, follow-up of up to 6 months after
the intervention will be considered short-term and
follow-up after the 6 months will be categorized as long-
term follow-up.
Data analysis
A narrative synthesis of the findings from the included
studies will be presented. The narrative synthesis will
focus on socio-demographic characteristics of the study
population, characteristics (study designs, settings, and
sample size) of the studies included, details of the inter-
ventions (type, content, duration, intensity, and theories
of change), effectiveness of the interventions, and pre-
defined outcome measures.
Measurement of intervention effects
For RCTs, NRCTs, and CBA studies, dichotomous out-
comes will be presented as risk ratio (RR), and if adjusted
analyses reported dichotomous outcomes (adjusting for
potential confounders) in terms of odds ratio (OR), Re-
view Manager (RevMan) 5.3 will be used to convert ORs
to RRs [49]. Anticipating that the included studies might
have used a variety of measures to assess the same out-
come, standardized mean difference (SMD) will be calcu-
lated for continuous outcomes.
For ITS studies, changes in the level of outcome (ex-
trapolating pre-intervention regression line to first point
post-intervention) and changes in trend (post-intervention
regression slope minus pre-intervention regression slope)
as determined by the included studies will be used.
Subgroup analysis and assessment of heterogeneity
Clinical heterogeneity will be assessed by examining the
characteristics of studies and similarities between the
types of participants and the interventions. Statistical
heterogeneity will be assessed by calculating I2 value. An
I2 value greater than 50% will be considered as indicative
of substantial heterogeneity. If sufficient information is
available from the included studies, subgroup analysis
will be performed to check if the intervention effect var-
ies with the study design and intervention characteristics
(timing, duration, and intensity of the intervention). Pro-
viding there is an adequate number of studies (n ≥ 10)
[46], meta-regression will be performed to identify
between-study heterogeneity (in terms of duration of
intervention and follow-up time).
Assessment of reporting bias
In case of appropriate number of studies (n ≥ 10), publi-
cation bias will be assessed by funnel plots for each out-
come by plotting the effect size against study size [46].
Data synthesis
Results from different study designs will not be pooled
together (for example, RCTs and NRS) to prevent a mis-
leading summary of the study effect [46]; rather, they
will be analyzed separately. When two or more studies
are sufficiently homogeneous and comparable across the
interventions, study designs, and outcomes measured,
random-effects model will be utilized for meta-analysis,
as it considers heterogeneity (within-study variance and
between-study variance) in the effect estimate [46]. Rev-
Man 5.3 will be used for statistical calculation [49]. Sta-
tistical differences for pooled SMD (for continuous
variables) will be assessed using Z test at 0.05 level of sig-
nificance. Similarly, for dichotomous data, the Mantel-
Haenszel method will be used to calculate RR and effect
sizes will be reported along with their 95% confidence
interval (CI). If the studies are methodologically diverse,
the findings will be presented descriptively only.
GRADE criteria will be used to assess the quality of
the evidence for each outcome as recommended in the
Cochrane Handbook for Systematic Reviews of Interven-
tions [46]. The quality of evidence will be rated as high,
moderate, low, and very low, and the factor that may de-
crease the quality of the evidence are study design, risk
of bias, inconsistency of results, indirectness (not
generalizable), imprecision (sparse data), and publication
bias [46]. The reason for downgrading the quality of evi-
dence will be provided. Summary of the findings will be
presented in a table, including pre-specified outcomes,
effect measures, number of studies and participants, and
grade of overall quality of the evidence.
Discussion
This protocol states the plan for a systematic review and
meta-analysis of effectiveness of DV interventions among
pregnant women in LMICs. Previous reviews were unable
to provide a firm conclusion that a specific intervention
was effective for addressing DV during pregnancy. This
review will carry out a thorough search of the existing evi-
dence for continued progress made, as well as an evalu-
ation of the quality of the evidence of DV interventions
available in LMICs. Whichever interventions service pro-
viders choose must be evidence-based and contextual.
However, it can be seen that the evidence-base for preven-
tion programs is over representative of developed coun-
tries in most cases. Therefore, this review will fill this gap
by generating an evidence-base on effectiveness of differ-
ent approaches for violence prevention and management
targeted for pregnant women in resource-constrained set-
tings. The findings could also point to the components,
modes of delivery, and theoretical underpinnings of inter-
ventions which can serve as valuable inputs for future re-
search in this area.
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